A novel digital health pathway enables healthcare technologies for gait and falls in Parkinson’s disease
moveIT improves healthcare for patients of Parkinson’s disease via wearable gait and fall sensors combined as a novel healthcare service by an innovative digital health pathway (DHP). The DHP defines the clinical application of these new technologies for stratified patient cohorts and multidisciplinary healthcare networks targeting gait and falls in PD.
Parkinson’s disease (PD), a chronic movement disorder characterised by progressive gait impairment, is the most common neurodegenerative movement disorder, affecting 10 million patients worldwide, with increasing prevalence in western societies. Gait impairment and falls greatly reduce quality of life for PD patients, lead to severe comorbidities and cause substantial healthcare costs.
Scientific evidence shows that adequate treatment may increase mobility, reduce risk of falling, prevent falls, and reduce costs. However, technologies to comprehensively monitor gait and falls are not available, or fail to qualify as a medical service or product, and can therefore not be applied clinically in multidisciplinary healthcare concepts to improve PD patient mobility.
The moveIT project will implement the first comprehensive gait and fall assessment battery integrated into a multidisciplinary healthcare concept, driven and organised by an innovative digital health pathway for gait and falls in PD. Existing well-characterised patient cohorts and state-of-the-art healthcare concepts will be used in a Living Lab to develop, test, and validate sensor-based movement assessments for application in clinical studies and patient care, ultimately preventing falls by moving PD healthcare into digital health.
The innovative digital health pathway for gait and falls in PD enables the placement of new digital health products and services, improves personalised patient care and reduces costs. moveIT targets the 1.2 million PD patients in Europe (with €14 billion annual healthcare costs), healthcare providers and payers, pharma companies, and medtech companies.
Partner classification: Education, Research, Hospital / University Hospital
Partner type: Core Partner
Founded in 1743, FAU has a rich history. It is a strong research university with an international perspective and one of the largest universities in Germany, with 39,780 students, 265 degree programmes and 4,000 academic staff. At Universitätsklinikum Erlangen (the university hospital), 7.400 employees promote health and cure disease. With up-to-date equipment and science-based diagnostic and therapeutic procedures, the 24 departments of the FAU, 25 clinical departments, 19 institutes, and 21 independent departments at Universitätsklinikum Erlangen comprehend every field of modern medicine.
Friedrich-Alexander-Universität Erlangen-Nürnberg, Schloßplatz 4, 91054 Erlangen, Germany
Key Activities in Research and Developement
Biomedical engineering, Life Sciences, Social sciences / health economics
Key Activities in Social Innovation
Key Activities in Business Creation
Incubation, Technology Transfer
Key Activities in Education
Entrepreneurship training, Technical faculties, Medical faculties
Partner classification: Business
Partner type: Core partner
Philips Electronics Nederland B.V.
Philips Electronics Nederland B.V., Boschdijk 525, 5622 Eindhoven, Netherlands
Key Activities in Corporate Innovation
Med Tech, ICT